Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Recruiting · NCT06541028 · Interventional (participants receive a specific treatment) · Lead sponsor: Yale University
View the official record on ClinicalTrials.gov →Interventions studied
Rapid-Start ART (RS-ART)
What this trial is about
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- PWID in general population:
- Be a PWID from the general population enrolling into ART services at one of the study's HIV clinics. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD).
- Provide informed consent.
- HIV clinicians prescribing ART
- Be the HIV clinician who prescribes ART for a PWID in one of the selected clinics.
- Be willing to use the RS-ART protocol.
- Be at least 18 years old. No minors below age 18 will be enrolled in the study.
- Provide informed consent.
- PWID in prison population:
- Be a PWID enrolling into ART services at Kajang prison. PWID can include patients injecting opioids, amphetamines, or other combinations of injectable drugs. Some of these patients may be diagnosed with Opioid Use Disorder (OUD).
- Provide informed consent.
Where it is running
3 locations listed.
- Kajang Prison - Kajang, Malaysia
- Centre of Excellence for Research in AIDS (CERiA) - University of Malaya - Kuala Lumpur, Malaysia
- Primary Healthcare Centers - Kuala Lumpur, Malaysia